These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 26331894

  • 1. The beginning of biological treatment era in the atopic dermatitis management.
    D'erme AM.
    Dermatol Ther; 2016 May; 29(3):208-9. PubMed ID: 26331894
    [No Abstract] [Full Text] [Related]

  • 2. Dupilumab (Dupixent) for moderate to severe atopic dermatitis.
    Med Lett Drugs Ther; 2017 Apr 24; 59(1519):64-66. PubMed ID: 28419072
    [No Abstract] [Full Text] [Related]

  • 3. EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers.
    Bakker DS, Ariens LFM, Giovannone B, Hijnen D, Delemarre EM, Knol E, Nierkens S, de Bruin-Weller MS, Thijs JL, Drylewicz J.
    Allergy; 2020 Dec 24; 75(12):3287-3289. PubMed ID: 33305359
    [No Abstract] [Full Text] [Related]

  • 4. Remittive effect of Dupilumab in atopic dermatitis.
    Treister AD, Lio PA.
    Dermatol Ther; 2018 Nov 24; 31(6):e12711. PubMed ID: 30253014
    [No Abstract] [Full Text] [Related]

  • 5. Diagnosis and management of moderate to severe adult atopic dermatitis: a Consensus by the Italian Society of Dermatology and Venereology (SIDeMaST), the Italian Association of Hospital Dermatologists (ADOI), the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC), and the Italian Society of Allergological, Environmental and Occupational Dermatology (SIDAPA).
    Calzavara Pinton P, Cristaudo A, Foti C, Canonica GW, Balato N, Costanzo A, DE Pità O, DE Simone C, Patruno C, Pellacani G, Peris K, Girolomoni G.
    G Ital Dermatol Venereol; 2018 Apr 24; 153(2):133-145. PubMed ID: 29237258
    [Abstract] [Full Text] [Related]

  • 6. Dupilumab: a revolutionary emerging drug in atopic dermatitis and its possible role in pemphigus.
    Tavakolpour S.
    Dermatol Ther; 2016 Sep 24; 29(5):299. PubMed ID: 26800435
    [No Abstract] [Full Text] [Related]

  • 7. Monoclonal antibodies for the treatment of atopic dermatitis.
    Renert-Yuval Y, Guttman-Yassky E.
    Curr Opin Allergy Clin Immunol; 2018 Aug 24; 18(4):356-364. PubMed ID: 29870461
    [Abstract] [Full Text] [Related]

  • 8. Recall dermatitis at patch test sites in an atopic dermatitis patient treated with dupilumab.
    Collantes-Rodríguez C, Jiménez-Gallo D, Ossorio-García L, Villegas-Romero I, Linares-Barrios M.
    Contact Dermatitis; 2019 Jan 24; 80(1):69-70. PubMed ID: 30334260
    [No Abstract] [Full Text] [Related]

  • 9. Eye Complications During Dupilumab Treatment for Severe Atopic Dermatitis.
    Ivert LU, Wahlgren CF, Ivert L, Lundqvist M, Bradley M.
    Acta Derm Venereol; 2019 Apr 01; 99(4):375-378. PubMed ID: 30653240
    [Abstract] [Full Text] [Related]

  • 10. Dupilumab for treatment of atopic dermatitis.
    Seegräber M, Srour J, Walter A, Knop M, Wollenberg A.
    Expert Rev Clin Pharmacol; 2018 May 01; 11(5):467-474. PubMed ID: 29557246
    [Abstract] [Full Text] [Related]

  • 11. Dupilumab: A review of its use in the treatment of atopic dermatitis.
    Gooderham MJ, Hong HC, Eshtiaghi P, Papp KA.
    J Am Acad Dermatol; 2018 Mar 01; 78(3 Suppl 1):S28-S36. PubMed ID: 29471919
    [Abstract] [Full Text] [Related]

  • 12. The future is finally here: Advances in the treatment of atopic dermatitis.
    Zirwas MJ.
    J Am Acad Dermatol; 2018 Mar 01; 78(3 Suppl 1):S25-S27. PubMed ID: 29248517
    [No Abstract] [Full Text] [Related]

  • 13. [Not Available].
    Lacour JP.
    Ann Dermatol Venereol; 2019 Dec 01; 146(12S3):12S76-12S84. PubMed ID: 31997736
    [Abstract] [Full Text] [Related]

  • 14. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.
    Beck LA, Thaçi D, Hamilton JD, Graham NM, Bieber T, Rocklin R, Ming JE, Ren H, Kao R, Simpson E, Ardeleanu M, Weinstein SP, Pirozzi G, Guttman-Yassky E, Suárez-Fariñas M, Hager MD, Stahl N, Yancopoulos GD, Radin AR.
    N Engl J Med; 2014 Jul 10; 371(2):130-9. PubMed ID: 25006719
    [Abstract] [Full Text] [Related]

  • 15. Dupilumab Versus Cyclosporine for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity Index.
    Ariëns LFM, Gadkari A, van Os-Medendorp H, Ayyagari R, Terasawa E, Kuznik A, Chen Z, Bégo-Le Bagousse G, Lu Y, Rizova E, Graham NMH, Pirozzi G, De Bruin-Weller M, Eckert L.
    Acta Derm Venereol; 2019 Sep 01; 99(10):851-857. PubMed ID: 31099402
    [Abstract] [Full Text] [Related]

  • 16. Are Biologics Efficacious in Atopic Dermatitis? A Systematic Review and Meta-Analysis.
    Snast I, Reiter O, Hodak E, Friedland R, Mimouni D, Leshem YA.
    Am J Clin Dermatol; 2018 Apr 01; 19(2):145-165. PubMed ID: 29098604
    [Abstract] [Full Text] [Related]

  • 17. Severe Adult Atopic Dermatitis: Clinical Challenges.
    Russo F, Flori ML, Gola M, Milanesi N.
    Dermatitis; 2020 Apr 01; 31(4):e48-e49. PubMed ID: 32209869
    [No Abstract] [Full Text] [Related]

  • 18. Targeted Treatment of Atopic Dermatitis.
    Metin SA, Wallace M.
    Skinmed; 2017 Apr 01; 15(2):137-138. PubMed ID: 28528610
    [No Abstract] [Full Text] [Related]

  • 19. New alcohol flushing in a patient with atopic dermatitis under therapy with dupilumab.
    Herz S, Petri M, Sondermann W.
    Dermatol Ther; 2019 Jan 01; 32(1):e12762. PubMed ID: 30288874
    [No Abstract] [Full Text] [Related]

  • 20. [Key-studies on dupilumab].
    Velter C.
    Ann Dermatol Venereol; 2018 Jan 01; 145(8-9):532-538. PubMed ID: 30093077
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.